By Christopher Norton ( March 18, 2010, 4:21 PM EDT) -- Congress has elected to leave out a proposed ban on "pay-for-delay" settlements between generic and brand-name drugmakers from its health care reform package, a policy idea beloved by consumer advocates but vigorously opposed by pharmaceutical industry interests....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.